Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
The FDA classifies it as a Category 2 bulk drug substance, noting potential safety concerns in unregulated compounding
Oher GLP-1 like lixsenatide (Sanofi Aventis, trade name Lyxumia) and albiglutide (GlaxoSmithKline, trade names Epezan and Tanseum) are currently approved or are under consideration for diabetes treatment (Ladenheim, 2015)
PMC Roles of nicotinamide N-methyltransferase in obesity and type 2 diabetes
Suh JH, Shenvi SV, Dixon BM, Liu H, Jaiswal AK, Liu R-M, et al
The Trial A total of 731 patients were randomly assigned to receive tirzepatide or placebo
US$ 28.09
US$ 26.89
US$ 20.10
US$ 28.38
US$ 28.87
US$ 29.52
US$ 22.65
US$ 29.37
US$ 26.97
US$ 22.85
